Tissue-preserving treatment with non-invasive physical plasma of cervical intraepithelial neoplasia—a prospective controlled clinical trial
Frontiers in Medicine · 15.08.2023 · 10
DOI: 10.3389/fmed.2023.1242732 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 15.08.2023. Verfasst von Martin Weiss und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's Health, University of Tübingen, Tübingen, Germany. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Cervical cancer represents the fourth leading cause of cancer among women and is associated with over 311,000 annual deaths worldwide. Timely diagnosis is crucial given the lengthy pre-cancerous phase, which is typified by cervical intraepithelial neoplastic lesions. However, current treatment methods are often tissue-destructive and can be accompanied by severe side effects. To address these concerns, our study introduces a novel, gentle approach for the tissue-preserving treatment of CIN lesions.
Results
We present findings of a controlled, prospective, single-armed phase IIb clinical trial performed at the Department for Women’s Health, Tübingen, Germany. From September 2017 to March 2022 we assessed 570 participants for study eligibility. Of the screened patients, 63 participants met with CIN1/2 lesions met the inclusion criteria and were treated with non-invasive physical plasma (NIPP). Assessment of treatment efficacy was based on a comprehensive analysis of histological and cytological findings, along with high-risk HPV infection load at 3 and 6 months post-treatment. Comparative analyses were performed retrospectively with data obtained from 287 untreated patients in the control group. Our findings indicate that patients treated with NIPP experienced an 86.2% rate of full remission, along with a 3.4% rate of partial remission of CIN lesions, which compares favorably to the control group’s rates of 40.4% and 4.5%, respectively. Additionally, we observed a twofold reduction in high-risk HPV infections following NIPP treatment. Minor side effects were observed, such as mild pain during treatment and short-term smear bleeding or increased vaginal discharge within 24 h after treatment. Given the experimental nature of NIPP treatment and the availability of established standard treatments, our study was designed as a non-randomized study.
Conclusion
NIPP treatment offers a highly flexible and easy-to-apply method for treating pre-cancerous CIN1/2 lesions. This non-invasive approach is notable for its tissue-preserving nature, making it a promising alternative to current excisional and ablative treatments. CIN1/2 lesions were employed as preliminary in vivo models for the targeted treatment of CIN3 lesions. Clinical trial registration https://www.clinicaltrials.gov , identifier NCT03218436.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Women's Health, University of Tübingen, Tübingen, Germany.
- NMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany.
- Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany.
- Department of Pathology and Neuropathology, University of Tübingen, Tübingen, Germany.
Zitieren
APA
Weiss, M., Arnholdt, M., Hißnauer, A., Fischer, I., Schönfisch, B., Andress, J., Gerstner, S., Dannehl, D., Bösmüller, H., Staebler, A., Brucker, S. Y., & Henes, M. (2023). Tissue-preserving treatment with non-invasive physical plasma of cervical intraepithelial neoplasia—a prospective controlled clinical trial. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1242732
Vancouver
Weiss M, Arnholdt M, Hißnauer A, Fischer I, Schönfisch B, Andress J, et al. Tissue-preserving treatment with non-invasive physical plasma of cervical intraepithelial neoplasia—a prospective controlled clinical trial. Frontiers in Medicine. 2023;10. doi:10.3389/fmed.2023.1242732
BibTeX
@article{Weiss2023,
author = {Weiss, Martin and Arnholdt, Marcel and Hißnauer, Anna and Fischer, Irma and Schönfisch, Birgitt and Andress, Jürgen and Gerstner, Sophia and Dannehl, Dominik and Bösmüller, Hans and Staebler, Annette and Brucker, Sara Y and Henes, Melanie},
title = {Tissue-preserving treatment with non-invasive physical plasma of cervical intraepithelial neoplasia—a prospective controlled clinical trial},
journal = {Frontiers in Medicine},
year = {2023},
volume = {10},
doi = {10.3389/fmed.2023.1242732}
}
EUVIMED